Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Iovance Biotherapeutics, Inc. - Common Stock
(NQ:
IOVA
)
4.230
-0.140 (-3.20%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Iovance Biotherapeutics, Inc. - Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
Got $1,500? Buy Iovance Biotherapeutics Now and Don't Look Back
↗
November 23, 2024
Via
The Motley Fool
2 Innovative Stocks That Could Deliver Outsize Returns
↗
November 22, 2024
Via
The Motley Fool
2 Top Biotech Stocks to Buy Now and Hold For 5 Years or More
↗
November 16, 2024
Via
The Motley Fool
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Third Quarter and Year to Date 2024
November 07, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
A Peek at Iovance Biotherapeutics's Future Earnings
↗
November 06, 2024
Via
Benzinga
Iovance Biotherapeutics to Host Third Quarter and Year-to-Date 2024 Financial Results Conference Call and Webcast on Thursday, November 7, 2024
October 31, 2024
Iovance also to Participate in Upcoming November Conferences
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
Is Iovance Biotherapeutics Stock a Buy?
↗
October 04, 2024
The biotech is making important breakthroughs, but is that enough?
Via
The Motley Fool
Why Iovance Biotherapeutics Stock Triumphed on Thursday
↗
October 24, 2024
With a cutting-edge melanoma drug now on the market, the company is positioned for a breakout.
Via
The Motley Fool
3 Reasons to Buy Iovance Biotherapeutics Stock Like There's No Tomorrow
↗
September 26, 2024
This biotech's growth story is going to start moving faster, and soon.
Via
The Motley Fool
3 Things You Need to Know if You Buy Iovance Biotherapeutics Today
↗
September 16, 2024
There's plenty of upside with this stock, but it might take a while to realize.
Via
The Motley Fool
AST SpaceMobile And Polestar Automotive Are Among Top 10 Best Performing Mid-Cap Stocks in August: Are The Others In Your Portfolio?
↗
September 08, 2024
The top 10 mid-cap stocks in August: Polestar Automotive, Upstart, Lumen Technologies, GDS Holdings, Tempus AI, Clear Secure, Iovance Biotherapeutics, Evolent Health, Semtech Corp, AST SpaceMobile.
Via
Benzinga
Topics
Artificial Intelligence
This Is the Biggest Risk With Iovance Biotherapeutics Stock
↗
September 06, 2024
Investors should brace for dilution.
Via
The Motley Fool
(IOVA) - Analyzing Iovance Biotherapeutics's Short Interest
↗
September 03, 2024
Via
Benzinga
Looking Into Iovance Biotherapeutics's Recent Short Interest
↗
August 16, 2024
Via
Benzinga
Iovance Biotherapeutics Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
↗
August 12, 2024
Via
Benzinga
Iovance Biotherapeutics to Present at Upcoming Conferences
September 03, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
3 Monster Biotech Stocks to Buy Before 2025
↗
September 02, 2024
These companies are nearly in the sweet spot of risk versus reward in biotech.
Via
The Motley Fool
Up 47% in 2024: Where Will Iovance Biotherapeutics Be in 5 Years?
↗
August 27, 2024
This company's new cancer therapy is producing remarkable results, but the company is losing money at a frightening pace.
Via
The Motley Fool
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
August 16, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
What the Options Market Tells Us About Iovance Biotherapeutics
↗
August 08, 2024
Via
Benzinga
This 1 Big Risk Is Also 1 Big Opportunity for Iovance Biotherapeutics Stock
↗
August 14, 2024
It could demonstrate a few capabilities that no other biotech has as of yet.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
↗
August 12, 2024
Via
Benzinga
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
↗
August 09, 2024
Via
Benzinga
Why Iovance Biotherapeutics Shares Are Soaring Today
↗
August 09, 2024
The biopharma company is proving its recently approved cancer therapy is marketable.
Via
The Motley Fool
Why Is Iovance Bio (IOVA) Stock Up 18% Today?
↗
August 09, 2024
Iovance Biotherapeutics stock is gaining as IOVA investors react to strong Q2 earnings beats and positive guidance for 2024 and 2025.
Via
InvestorPlace
Topics
Earnings
Skin Cancer-Focused Iovance Biotherapeutics Reports Better-Than-Expected 2024, 2025 Outlook, Stock Surges
↗
August 09, 2024
Iovance Biotherapeutics stock up 23.2% after issuing upbeat guidance for 2024 and 2025, beating Q2 earnings expectations.
Via
Benzinga
Why Doximity Shares Are Trading Higher By Over 28%; Here Are 20 Stocks Moving Premarket
↗
August 09, 2024
Via
Benzinga
IOVA Stock Earnings: Iovance Biotherapeutics Beats EPS, Beats Revenue for Q2 2024
↗
August 08, 2024
IOVA stock results show that Iovance Biotherapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2024
August 08, 2024
From
Iovance Biotherapeutics, Inc.
Via
GlobeNewswire
10 Best Small and Mid-Cap Stocks to Consider Buying in August
↗
August 01, 2024
A shift in market dynamics could favor these 10 growth stocks.
Via
The Motley Fool
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
23
24
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
